NVKFB-Proefschriftprijs
Proefschriftprijscommissie |
|
| Prof. dr. G.J. Groeneveld (voorzitter) | Prof. dr. E.L. Swart (secretaris) |
| Dr. F. Vanmolkot | |
Reglement
Hier treft u de meest recent versie aan van het Reglement proefschriftprijs NVKFB- mei 2026.
Winnaars Proefschriftprijrijs/s NVKFB
| 2025 | Dr. Stefanie Krens: Optimizing anticancer drug exposure in routine clinical care – beyond the blueprint Promotor: Prof. dr. P.H. van Erp. Co-promotor: Prof. dr. F.G.A. Jansman, Prof. dr. C.M.L. van Herpen en Prof. dr. D.M. Burger |
| 2024 | Dr. Tom Jacobs: Accelerating access to optimal anti-infective treatment for children living with HIV Promotor: prof. dr. David Burger. Co-promotor: dr. Angela Colbers |
| 2023 | Dr. Johan van der Plas: Advances in clinical development for vaccines and therapeutics against respiratory virus infections Promotor: prof. dr. Koos Burggraaf. Co-promotor: dr. Ingrid de Visser-Kamerling |
| 2022 | Dr. Bastiaan Sallevelt: Medication optimisation in hospitalised older people with polypharmacy and multimorbidityPromotoren: prof. dr. Toine Egberts en prof. dr. Eugène van Puijenbroek. Co-promotoren: dr. Ingeborg Wilting en dr. Wilma Knol |
| 2021 | Dr. Semra Palić: Clinical pharmacology of Miltefosine – Application of modeling and simulation to advance treatment of leishmaniasisPromotor: prof. dr. Jos Beijnen. Co-promotor: dr. Thomas Dorlo |
| 2020 | Dr. Paola Mian: Descriptive pharmacokinetics and physiologically based predictions of paracetamol and its metabolites in special populationsPromotores: Prof. dr. D. Tibboel, Prof. dr. K.M. Allegaert |
| 2019 | Dr. Linda G.W. Franken: Drug dosing at the end of life – A pharmacometric approachPromotor: Prof. dr. T. van Gelder, Prof. dr. R.A.A. Mathôt, Dr. B.C.P. Koch |
| 2018 | Dr. J.M. Bos: Improving medication safety in surgical patients. Impact of a multifaceted interventionPromotor: Prof. dr. G.J. van der Wilt, Prof. dr. P.A.G.M. de Smet, Prof. dr. P.M.L.A. van den Bent. Copromotor: Prof. dr. C. Kramers |
| 2017 | Dr. G.M.C. Masclee: Effects of Non-Steroidal Anti-Inflammatory Drugs on the Gastrointestinal and Cardiovascular SystemPromotor: Prof. dr. M.C.J.M. Sturkenboom, Prof. dr. E.J. Kuipers. Copromotor: Dr. P.M. Coloma |
| 2016 | Dr. D. Meulendijks: Improving Safety and Effectiveness of Fluoropyrimidine-Based ChemotherapyPromotor: Prof. dr. J.H.M. Schellens, Prof. dr. J.H. Beijnen, Dr. A. Cats |
| 2015 | Dr. P. van Rijn-Bikker: Variability in Response to Antihypertensive Drug Therapy: From Population Based Therapy towards Individualized TreatmentPromotor: Prof. dr. R.P. Koopmans, Prof. dr. R.A.A. Mathôt. Copromotor: Dr. R.M. van Hest |
| 2014 | Dr. Q. Fillekes: Joining forces in the fight against HIV/AIDS in Africa: Clinical pharmacology studies in pregnant women and childrenPromotor: Prof. dr. D.M. Burger. Copromotor: Dr. A.S. Walker |
| 2013 | Dr. E. Krekels: Size Does Matter : Drug Glucuronidation in ChildrenPromotores: Prof. dr. C.A.J. Knibbe en Prof. dr. D. Tibboel |
| 2012 | Dr. R. Brüggemann: The road to tailor-made azole antifungal therapyPromotor: Prof. dr. D.M. Burger, Prof. dr. P.E. Verweij, Dr. A. Warris, Prof. dr. N.M.A. Blijlevens |
| 2012 | Dr. J.J. Swen: Translating pharmacogenetics to primary care Promotor: Prof. dr. H.J. Guchelaar, Prof. dr. W.J.J. Assendelft. Co-promotor: Dr. J.A.M. Wessels |
| 2011 | Dr. A.M. Harmsze: Influence of Genetic Variants and Drug Interactions on the Response to Antiplatelet DrugsPromotor: Prof. dr. A. de Boer. Co-promotoren: Dr. V.H.M. Deneer, Dr. O.H. Klungel |
| 2010 | Dr. M.L. Becker: Individualizing Pharmacotherapy. Genetic factors and co-prescribed drugs affecting pharmacotherapyPromotores: Prof. dr. B.H.Ch. Stricker, prof. dr. A.G. Vulto. Co-promotor: Dr. L.E. Visser |
| 2009 | Dr. R.F.A. L’homme: North-South collaboration in clinical pharmacological research of HIV treatmentPromotor: prof. dr. Y.A. Hekster Co-promotor: Dr. D.M. Burger |
| 2008 | Dr. T. Schalekamp: Efects of CYP2C9 and VKORC1 polymorphisms and drug interactions on coumarin anticoagulation controlPromotor: Prof. dr. A. de Boer |
| 2007 | Dr. N.P. Riksen: Adenosine in health and disease : a human in vivo study on genetic, metabolic, and pharmacological determinants of the cardiovascular effects of adenosinePromotor: Prof. dr. P. Smits, Copromotor: Dr. G.A. Rongen |
| 2006 | Dr. Luc JJ Derijks: Thiopurines in Inflammatory Bowel Disease. New strategies for optimization of pharmacotherapyPromotores: Prof. dr. S.J.H. van Deventer en Prof. dr. C.J.J. Mulder. Co-promotores: Dr. L.G.J.B. Engels, Dr. D.W. Hommes, Dr. P.M. Hooymans |
| 2005 | Dr. A. Wegman: N-of-1 trials in general practice: tailoring treatment to individual patientsPromotores: Prof. dr. Th.P.G.M. de Vries en Prof. dr. W.A.B. Stalman. Co-promotor: Dr. D.A.W.M. van der Windt |
| 2004 | Dr. A.S. Bergshoeff: Exploring the Clinical Pharmacology of Antiretroviral Agents in HIV-1 Infected ChildrenPromotores: Prof. dr. Y.A. Hekster, Prof. dr. R. de Groot. Co-promotor: Dr. D.M. Burger |
| 2003 | Dr. C.A.J. Knibbe: Pharmacokinetics, pharmacodynamics and safety of different propofol formulations. Comparative pharmacology in rats, surgical patients, intensive care patients and childrenPromotor: Prof. dr. M. Danhof. Co-promotores: Dr. L.P.H.J. Aarts en r. P.F.M. Kuks |
| 2002 | Dr. S. Natsch: Improving the quality of use of antimicrobial drugs Assessments and interventionsPromotores: Prof. dr. J.W.M. van der Meer, Prof. dr. Y.A. Hekster. Co-promotor: Dr. B.J. Kullberg |
| 2001 | Dr. A. Huitema: Population Pharmacokinetics and Pharmacokinetically Guided Dosing of Cyclophosphamide, Thiotepa and Carboplatin in High-Dose ChemotherapyPromotores: Prof. dr. J. Beijnen Prof. dr. S Rodenhuis. Co-promotor: Dr. R.A.A. Mathôt |
| 2000 | Dr. T. Dormans: Diuretic, vascular and ototoxic effects of high dose furosemidePromotores: Prof. dr. P. Smits. Co-promotoren: Dr P.G. Gerlag, Dr. F.G.M. Russel |
| 1999 | Dr. R.M.W. Hoetelmans: Clinical pharmacology of antiretroviral drugs |
| 1998 | Dr. G. Rongen: Vascular pharmacology of adenosine and adenosine-5’-triphosphate in humansPromotores: Prof. dr. P. Smits en Prof.dr. T. Thien Co-promotor: dr. J.W.M. Lenders |
| 1997 | Dr. M.T. Huizing: Bioanalysis and clinical pharmacology of paclitaxel |